NOS2 and neoplasm: Used primarily as a vasodilatory agent, sildenafil is also known to decrease MDSC Arg1 and iNOS expression, leading to decreased immunosuppressive capabilities; increased CD8 + T cell activation; and reduced tumor metastasis in several cancer models [170,171,172].